Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Michael

Showing results (101-110 of 216) with videos related to

Pageof 22
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 24, 2022
The impact of molecular and mismatch repair status on the survival outcomes of surgically treated patients with colorectal peritoneal metastasesMichael P Flood, Anshini Jain, Catherine Mitchell, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2017
Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
Chemotherapy|December 9, 2008
A pilot human evaluation of a formulation of irinotecan and hyaluronic acid in 5-fluorouracil-refractory metastatic colorectal cancer patientsPeter Gibbs, Tracey J Brown, Raymond Ng, et al.
Cancers|September 27, 2025
Real-World Outcomes Between Perioperative Chemotherapy (FLOT) and Preoperative Concurrent Chemoradiotherapy (CROSS) in Localized Esophageal and Esophagogastric Junction Adenocarcinoma: A Retrospective Cohort StudyJirapat Wonglhow, Hui-Li Wong, Cuong Duong, et al.
Langenbeck'S Archives of Surgery|September 8, 2021
Pelvic exenteration, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: experience and outcomes from an exenterative and peritonectomy unitMichael P Flood, Peadar S Waters, Mikael Soucisse, et al.
Journal of the National Cancer Institute|March 8, 2026
Long-term survival outcomes after biomarker-guided thromboprophylaxis in cancer: extended follow-up of the TARGET-TP randomised trialJennifer Rogers, Michael Michael, Jeanne Tie, et al.
Endocrine Oncology (Bristol, England)|December 8, 2025
Exploring the carcinoid crisis: insights from a cancer-specific centreMaribel Del Olmo-García, Grace Kong, HuiLi Wong, et al.
Heart, Lung & Circulation|August 7, 2019
Early Outcomes of Surgery for Carcinoid Heart DiseaseMatthew S Yong, Grace Kong, Prakash Ludhani, et al.
Heliyon|May 2, 2024
Side effects of CoronaVac® COVID-19 vaccination: Investigation in North Jakarta district public health center communities in IndonesiaDiana Laila Ramatillah, Siew Hua Gan, Judith Novarticia, et al.
Breast (Edinburgh, Scotland)|December 25, 2010
Rational use of trastuzumab in metastatic and locally advanced breast cancer: implications of recent researchShom Goel, Jacquie Chirgwin, Prudence Francis, et al.
Pageof 22

Showing results (101-110 of 216) with videos related to

Sort By:
Pageof 22
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 24, 2022
The impact of molecular and mismatch repair status on the survival outcomes of surgically treated patients with colorectal peritoneal metastasesMichael P Flood, Anshini Jain, Catherine Mitchell, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2017
Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
Chemotherapy|December 9, 2008
A pilot human evaluation of a formulation of irinotecan and hyaluronic acid in 5-fluorouracil-refractory metastatic colorectal cancer patientsPeter Gibbs, Tracey J Brown, Raymond Ng, et al.
Cancers|September 27, 2025
Real-World Outcomes Between Perioperative Chemotherapy (FLOT) and Preoperative Concurrent Chemoradiotherapy (CROSS) in Localized Esophageal and Esophagogastric Junction Adenocarcinoma: A Retrospective Cohort StudyJirapat Wonglhow, Hui-Li Wong, Cuong Duong, et al.
Langenbeck'S Archives of Surgery|September 8, 2021
Pelvic exenteration, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: experience and outcomes from an exenterative and peritonectomy unitMichael P Flood, Peadar S Waters, Mikael Soucisse, et al.
Journal of the National Cancer Institute|March 8, 2026
Long-term survival outcomes after biomarker-guided thromboprophylaxis in cancer: extended follow-up of the TARGET-TP randomised trialJennifer Rogers, Michael Michael, Jeanne Tie, et al.
Endocrine Oncology (Bristol, England)|December 8, 2025
Exploring the carcinoid crisis: insights from a cancer-specific centreMaribel Del Olmo-García, Grace Kong, HuiLi Wong, et al.
Heart, Lung & Circulation|August 7, 2019
Early Outcomes of Surgery for Carcinoid Heart DiseaseMatthew S Yong, Grace Kong, Prakash Ludhani, et al.
Heliyon|May 2, 2024
Side effects of CoronaVac® COVID-19 vaccination: Investigation in North Jakarta district public health center communities in IndonesiaDiana Laila Ramatillah, Siew Hua Gan, Judith Novarticia, et al.
Breast (Edinburgh, Scotland)|December 25, 2010
Rational use of trastuzumab in metastatic and locally advanced breast cancer: implications of recent researchShom Goel, Jacquie Chirgwin, Prudence Francis, et al.
Pageof 22